{"abstract": "GlaxoSmithKline and Pfizer plan to spin out and combine their H.I.V. research units, choosing an alternative to the big mergers that have been transforming the industry.", "web_url": "https://dealbook.nytimes.com/2009/04/17/a-different-kind-of-drug-deal/", "snippet": "GlaxoSmithKline and Pfizer plan to spin out and combine their H.I.V. research units, choosing an alternative to the big mergers that have been transforming the industry.", "lead_paragraph": "The rapid consolidation in the pharmaceutical industry continued Thursday as GlaxoSmithKline and Pfizer, two rival drug makers, agreed to spin out and combine their H.I.V. research units into a new company.", "source": "The New York Times", "multimedia": [], "headline": {"main": "A Different Kind of Drug Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-04-17T11:10:40+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/4770809a-fbb3-5940-b0a5-16714cfac3bc", "word_count": 342, "uri": "nyt://article/4770809a-fbb3-5940-b0a5-16714cfac3bc"}